ESR1 and breast cancer: A number of signaling pathways are particularly relevant in BC cells: the ER-signaling and Her2-signaling pathways for ER+ and HER2+ tumors, as well as the Wnt/β-catenin and PI3K/Akt/mTOR pathways.